David Ebersman
American businessman
title: "David Ebersman" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["american-chief-financial-officers", "facebook-employees", "living-people", "american-chief-executives-in-technology", "brown-university-alumni", "trinity-school-(new-york-city)-alumni", "genentech-people", "20th-century-american-businesspeople", "21st-century-american-businesspeople", "businesspeople-from-new-york-city", "henry-crown-fellows", "1969-births"] description: "American businessman" topic_path: "geography/united-states" source: "https://en.wikipedia.org/wiki/David_Ebersman" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0
::summary American businessman ::
::data[format=table title="Infobox person"]
| Field | Value |
|---|---|
| name | David Ebersman |
| image | David Ebersman, The Grove 2022 (cropped).jpg |
| caption | Ebersman in 2022 |
| birth_date | |
| education | Brown University |
| :: |
| name = David Ebersman | image = David Ebersman, The Grove 2022 (cropped).jpg | caption = Ebersman in 2022 | birth_date = | education = Brown University
David A. Ebersman (born 1969) is an American businessman and the co-founder and chief executive officer of Lyra Health. He previously served as chief financial officer of Facebook and Genentech. At Facebook, Ebersman orchestrated the largest U.S. Internet IPO of all time and set a record for CFO stock sales.
Early life
David Ebersman was born in 1969. He attended the Trinity School in New York City, graduating in 1987. Ebersman attended Brown University and graduated in June 1991 with an AB in international relations and Economics.
Career
Ebersman began his professional career at Oppenheimer & Co, Inc. in September 1991 as a Research Analyst. Ebersman left Oppenheimer & Co in February 1994 and began working for Genentech. He served as executive vice president and CFO of the company between 2006 and 2009.
In September 2009, Ebersman joined Facebook as the company's chief financial officer, hired in part because he had "public company experience". He oversaw the company's initial public offering on May 18, 2012—then the largest U.S. Internet offering of all time. The IPO proved controversial after the company's market value dropped significantly over the following weeks. In a New York Times article, Andrew Ross Sorkin pointed to Ebersman's culpability for the "catastrophe of an initial public offering," writing "if there is one single individual more responsible than any other for the staggering mispricing of Facebook's I.P.O., it is Mr. Ebersman."
In November 2013, Ebersman set a record for CFO stock sales when he cashed in more than 900,000 shares of Facebook stock worth $42.6 million. He sold $26.2 million more worth of stock in December of that year. Ebersman stepped down from his role at Facebook in June 2014 and was succeeded by David Wehner.
Lyra Health
In May 2015, Ebersman announced the launch of Lyra Health, a mental health care startup. In 2021, the company was valued at $4.6 billion.
Ebersman serves on the boards of Castlight Health and SurveyMonkey, where he is chairman of the board.
References
References
- CNBC. (2012-05-22). "David Ebersman".
- Jennings, Katie. "Health Insurance For Mental Health Is Terrible. This $4.6 Billion Startup Is Shaking Up The Status Quo.".
- (2009-06-29). "Facebook hires former Genentech exec Ebersman as its new CFO".
- Albergotti, Reed. (2014-04-23). "Facebook CFO Ebersman to Step Down Two Years After IPO". Wall Street Journal.
- Blodget, Henry. "We Just Found Someone Who Knew Facebook's CFO David Ebersman When He Was In High School...".
- David A. Ebersman. (April 2023). "David Ebersman: Executive Profile & Biography – Businessweek". Investing.businessweek.com.
- (2009-06-29). "Facebook hires former Genentech exec as CFO". ZDNet.
- (2012-02-01). "Going Public: Key Developments in Facebook's IPO – ABC News". Abcnews.go.com.
- Andrew Ross Sorkin. "DEALBOOK; The Man Behind Facebook's I.P.O. Debacle".
- Jennings, Katie. "Lyra Health Hits $1.1 Billion Valuation, As Coronavirus Boosts Need For Teletherapy".
- "David a Ebersman, Lyra Health Inc: Profile and Biography".
- Jennings, Katie. "Lyra Health Hits $1.1 Billion Valuation, As Coronavirus Boosts Need For Teletherapy".
::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::